John J. Sperzel Iii.
Chief Executive Officer, CHEMBIO DIAGNOSTICS, INC.
Companies
- T2 Biosystems, Inc.Board member Jan 14, 2020 to Jan 2, 20251
- T2 Biosystems, Inc.Officer Jan 14, 2020 to Jan 2, 20251
- T2 Biosystems, Inc.Chair Apr 11, 2022 to Mar 9, 20232
- T2 Biosystems, Inc.Chief executive officer Mar 19, 2021 to Mar 9, 20233
- T2 Biosystems, Inc.President Mar 19, 2021 to Apr 11, 20223
- CHEMBIO DIAGNOSTICS, INC.Officer Oct 10, 2018 to Jun 25, 20194
- CHEMBIO DIAGNOSTICS, INC.Board member Apr 4, 2017 to Jun 25, 20195
- CHEMBIO DIAGNOSTICS, INC.Chief executive officer Mar 17, 2014 to Apr 4, 20176
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- T2 Biosystems, Inc.400 shares7Feb 24, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 24, 2024Exercised options 67 shares of T2 Biosystems, Inc.7
- Feb 20, 2024Exercised options 160 shares of T2 Biosystems, Inc.8
- Feb 28, 2023Sold 2,898 shares at $0.59 of T2 Biosystems, Inc.9
- Feb 24, 2023Exercised options 6,667 shares of T2 Biosystems, Inc.9
- Feb 22, 2023Sold 6,875 shares at $0.65 of T2 Biosystems, Inc.9
- Feb 20, 2023Exercised options 16,000 shares of T2 Biosystems, Inc.9
- Apr 7, 2022Bought 30,000 shares at $0.50 of T2 Biosystems, Inc.10
- Feb 24, 2022Shares withheld for tax 141,560 shares at $0.45 of T2 Biosystems, Inc.11
- Feb 24, 2022Exercised options 333,333 shares of T2 Biosystems, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGART2 Biosystems, Inc., Board member
- 2SEC EDGART2 Biosystems, Inc., Chair
- 3
- 4SEC EDGARCHEMBIO DIAGNOSTICS, INC., Officer
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Feb 20, 2024
- 9SEC EDGARForm 4 filed Mar 9, 2023
- 10SEC EDGARForm 4 filed Apr 11, 2022
- 11SEC EDGARForm 4 filed Feb 28, 2022